United States Prophylactic Human Vaccines Market Report 2016

United States Prophylactic Human Vaccines Market Report 2016

1 Prophylactic Human Vaccines Overview

1.1 Product Overview and Scope of Prophylactic Human Vaccines

1.2 Classification of Prophylactic Human Vaccines

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Prophylactic Human Vaccines

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Prophylactic Human Vaccines (2011-2021)

1.4.1 USA Prophylactic Human Vaccines Sales and Growth Rate (2011-2021)

1.4.2 USA Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)

2 USA Prophylactic Human Vaccines Competition by Manufacturers

2.1 USA Prophylactic Human Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Prophylactic Human Vaccines Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Prophylactic Human Vaccines Average Price by Manufactures (2015 and 2016)

2.4 Prophylactic Human Vaccines Market Competitive Situation and Trends

2.4.1 Prophylactic Human Vaccines Market Concentration Rate

2.4.2 Prophylactic Human Vaccines Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Prophylactic Human Vaccines Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Prophylactic Human Vaccines Sales and Market Share by Type (2011-2016)

3.2 USA Prophylactic Human Vaccines Revenue and Market Share by Type (2011-2016)

3.3 USA Prophylactic Human Vaccines Price by Type (2011-2016)

3.4 USA Prophylactic Human Vaccines Sales Growth Rate by Type (2011-2016)

4 USA Prophylactic Human Vaccines Sales (Volume) by Application (2011-2016)

4.1 USA Prophylactic Human Vaccines Sales and Market Share by Application (2011-2016)

4.2 USA Prophylactic Human Vaccines Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Prophylactic Human Vaccines Manufacturers Profiles/Analysis

5.1 ALK - Abello A/S (Denmark)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Altimmune, Inc. (US)

5.2.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Altimmune, Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Bavarian Nordic A/S (Denmark)

5.3.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 BiondVax Pharmaceuticals Ltd. (Israel)

5.4.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Bharat Biotech International Limited (India)

5.5.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Bharat Biotech International Limited (India) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 GlaxoSmithKline Plc. (UK)

5.6.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Hualan Biological Engineering Inc. (China)

5.7.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Janssen Pharmaceuticals, Inc. (US)

5.8.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 MedImmune (US)

5.9.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 MedImmune (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Merck & Co., Inc. (US)

5.10.2 Prophylactic Human Vaccines Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Merck & Co., Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Pfizer Inc. (US)

5.12 Sanofi Pasteur SA (France)

5.13 Serum Institute of India Pvt. Ltd. (India)

5.14 Shanghai BravoBio Co., Ltd. (China)

5.15 Seqirus (UK)

5.16 SK Chemicals Co., Ltd. (Korea)

5.17 Takeda Pharmaceutical Company Limited (Japan)

5.18 Zydus Cadila (India)

6 Prophylactic Human Vaccines Manufacturing Cost Analysis

6.1 Prophylactic Human Vaccines Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Prophylactic Human Vaccines

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Prophylactic Human Vaccines Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Prophylactic Human Vaccines Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Prophylactic Human Vaccines Market Forecast (2016-2021)

10.1 USA Prophylactic Human Vaccines Sales, Revenue Forecast (2016-2021)

10.2 USA Prophylactic Human Vaccines Sales Forecast by Type (2016-2021)

10.3 USA Prophylactic Human Vaccines Sales Forecast by Application (2016-2021)

10.4 Prophylactic Human Vaccines Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Prophylactic Human Vaccines

Table Classification of Prophylactic Human Vaccines

Figure USA Sales Market Share of Prophylactic Human Vaccines by Type in 2015

Table Application of Prophylactic Human Vaccines

Figure USA Sales Market Share of Prophylactic Human Vaccines by Application in 2015

Figure USA Prophylactic Human Vaccines Sales and Growth Rate (2011-2021)

Figure USA Prophylactic Human Vaccines Revenue and Growth Rate (2011-2021)

Table USA Prophylactic Human Vaccines Sales of Key Manufacturers (2015 and 2016)

Table USA Prophylactic Human Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Prophylactic Human Vaccines Sales Share by Manufacturers

Figure 2016 Prophylactic Human Vaccines Sales Share by Manufacturers

Table USA Prophylactic Human Vaccines Revenue by Manufacturers (2015 and 2016)

Table USA Prophylactic Human Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Prophylactic Human Vaccines Revenue Share by Manufacturers

Table 2016 USA Prophylactic Human Vaccines Revenue Share by Manufacturers

Table USA Market Prophylactic Human Vaccines Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Prophylactic Human Vaccines Average Price of Key Manufacturers in 2015

Figure Prophylactic Human Vaccines Market Share of Top 3 Manufacturers

Figure Prophylactic Human Vaccines Market Share of Top 5 Manufacturers

Table USA Prophylactic Human Vaccines Sales by Type (2011-2016)

Table USA Prophylactic Human Vaccines Sales Share by Type (2011-2016)

Figure USA Prophylactic Human Vaccines Sales Market Share by Type in 2015

Table USA Prophylactic Human Vaccines Revenue and Market Share by Type (2011-2016)

Table USA Prophylactic Human Vaccines Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Prophylactic Human Vaccines by Type (2011-2016)

Table USA Prophylactic Human Vaccines Price by Type (2011-2016)

Figure USA Prophylactic Human Vaccines Sales Growth Rate by Type (2011-2016)

Table USA Prophylactic Human Vaccines Sales by Application (2011-2016)

Table USA Prophylactic Human Vaccines Sales Market Share by Application (2011-2016)

Figure USA Prophylactic Human Vaccines Sales Market Share by Application in 2015

Table USA Prophylactic Human Vaccines Sales Growth Rate by Application (2011-2016)

Figure USA Prophylactic Human Vaccines Sales Growth Rate by Application (2011-2016)

Table ALK - Abello A/S (Denmark) Basic Information List

Table ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ALK - Abello A/S (Denmark) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Altimmune, Inc. (US) Basic Information List

Table Altimmune, Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Altimmune, Inc. (US) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Bavarian Nordic A/S (Denmark) Basic Information List

Table Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bavarian Nordic A/S (Denmark) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information List

Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table BiondVax Pharmaceuticals Ltd. (Israel) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Bharat Biotech International Limited (India) Basic Information List

Table Bharat Biotech International Limited (India) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bharat Biotech International Limited (India) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table GlaxoSmithKline Plc. (UK) Basic Information List

Table GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Plc. (UK) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Hualan Biological Engineering Inc. (China) Basic Information List

Table Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hualan Biological Engineering Inc. (China) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Janssen Pharmaceuticals, Inc. (US) Basic Information List

Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Pharmaceuticals, Inc. (US) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table MedImmune (US) Basic Information List

Table MedImmune (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table MedImmune (US) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Merck & Co., Inc. (US) Basic Information List

Table Merck & Co., Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co., Inc. (US) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Pfizer Inc. (US) Basic Information List

Table Pfizer Inc. (US) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Inc. (US) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Sanofi Pasteur SA (France) Basic Information List

Table Sanofi Pasteur SA (France) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi Pasteur SA (France) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Serum Institute of India Pvt. Ltd. (India) Basic Information List

Table Serum Institute of India Pvt. Ltd. (India) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Serum Institute of India Pvt. Ltd. (India) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Shanghai BravoBio Co., Ltd. (China) Basic Information List

Table Shanghai BravoBio Co., Ltd. (China) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shanghai BravoBio Co., Ltd. (China) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Seqirus (UK) Basic Information List

Table Seqirus (UK) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Seqirus (UK) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table SK Chemicals Co., Ltd. (Korea) Basic Information List

Table SK Chemicals Co., Ltd. (Korea) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table SK Chemicals Co., Ltd. (Korea) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List

Table Takeda Pharmaceutical Company Limited (Japan) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Zydus Cadila (India) Basic Information List

Table Zydus Cadila (India) Prophylactic Human Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)

Table Zydus Cadila (India) Prophylactic Human Vaccines Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Prophylactic Human Vaccines

Figure Manufacturing Process Analysis of Prophylactic Human Vaccines

Figure Prophylactic Human Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Prophylactic Human Vaccines Major Manufacturers in 2015

Table Major Buyers of Prophylactic Human Vaccines

Table Distributors/Traders List

Figure USA Prophylactic Human Vaccines Production and Growth Rate Forecast (2016-2021)

Figure USA Prophylactic Human Vaccines Revenue and Growth Rate Forecast (2016-2021)

Table USA Prophylactic Human Vaccines Production Forecast by Type (2016-2021)

Table USA Prophylactic Human Vaccines Consumption Forecast by Application (2016-2021)